Related Experiment Video
Updated: Feb 26, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
Published on: January 7, 2019
Epithelial membrane protein 2: Molecular interactions and clinical implications
Lawrance K Chung1, Nikhilesh S Bhatt1, Carlito Lagman1
1Department of Neurosurgery, University of California, Los Angeles, 300 Stein Plaza, Suite 420, Los Angeles, CA 90095, USA.
Epithelial membrane protein 2 (EMP2) shows promise as a biomarker and therapeutic target for glioblastoma and other cancers. Further research into EMP2's normal biological functions is crucial for clinical translation of antibody therapies.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Immunotherapy
Background:
- Epithelial membrane protein 2 (EMP2) is a cell surface protein implicated in cancer prognosis.
- EMP2 is associated with glioblastoma and other human cancers.
- Its extracellular domains and matrix association make EMP2 a potential therapeutic target.
Purpose of the Study:
- To review current research on EMP2 in neuro-oncology.
- To discuss the potential of EMP2 as a biomarker and target for antibody therapies.
- To predict future research directions for clinical applications.
Main Methods:
- Comprehensive literature review of preclinical and translational studies.
- Analysis of EMP2's role in cancer prognosis and therapeutic targeting.
- Exploration of EMP2's molecular interactions and biological functions.
Main Results:
- Preclinical studies indicate EMP2 is linked to disease prognosis in cancers like glioblastoma.
- Antibody-based targeting of EMP2 shows potential for improved tumor control and survival in preclinical models.
- Understanding EMP2's role in normal physiology is key for clinical translation.
Conclusions:
- EMP2 is a promising target for antibody-based cancer therapies, particularly in neuro-oncology.
- Further research is needed to elucidate EMP2's function in normal tissues for safe and effective clinical application.
- Translational efforts are essential to move EMP2-targeted therapies from preclinical success to patient benefit.
Related Concept Videos
Overview of Cell-Matrix Interactions
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Protein-protein Interfaces
Mitogens and the Cell Cycle
Mechanisms of Membrane Domain Formation
Another mechanism for membrane domain formation involves membrane proteins interacting with...
Intracellular Signaling Affects Focal Adhesions
Some...

